3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
140
Myelodysplastic Syndromes
123
Myeloproliferative Disorders
103
Leukemia, Myeloid, Acute
99
Leukemia
67
Precursor Cell Lymphoblastic Leukemia-Lymphoma
53
Multiple Myeloma
52
Lymphoma
49
Primary Myelofibrosis
43
Polycythemia Vera
43
Leukemia, Lymphocytic, Chronic, B-Cell
40
Lymphoma, Non-Hodgkin
39
Hodgkin Disease
35
Leukemia, Myelomonocytic, Chronic
31
Thrombocythemia, Essential
30
Leukemia, Myeloid, Chronic-Phase
30
Hematologic Neoplasms
29
Neoplasms
27
Lymphoma, Follicular
27
Mastocytosis
26
Myelodysplastic-Myeloproliferative Diseases
24
Lymphoma, Large B-Cell, Diffuse
23
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
23
Leukemia, Myeloid, Accelerated Phase
23
Blast Crisis
23
Neoplasms, Plasma Cell
22
Congenital Abnormalities
22
Lymphoma, Mantle-Cell
21
Lymphoma, B-Cell, Marginal Zone
21
Leukemia, Hairy Cell
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Spondylarthritis
×
Myeloid
×
Clear all
NCT02450396
2026-03-27
EGR2
Assistance Publique - Hôpitaux de Paris
Withdrawn